NTHI Stock Summary and Trading Ideas (Neonc Technologies Hldgs | NASDAQ:NTHI)

NeOnc Technologies Holdings Inc. is the developer of a novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. The company product includes NEO100, which commenced Phase 2a clinical trials, which is used for treating glioblastoma, and has Orphan Drug and Fast Track designation from the United States Food and Drug Administration (FDA).

What symbol and exchange does Neonc Technologies Hldgs shares trade?

Neonc Technologies Hldgs trades on the NASDAQ stock market under the symbol NTHI.

What is Neonc Technologies Hldgs stock price doing today?

As of March 20, 2026, NTHI stock price declined to $7.31 with 53,573 million shares trading.

What is Neonc Technologies Hldgs's Beta?

NTHI has a beta of 1.85, meaning it tends to be more sensitive to market movements. NTHI has a correlation of 0.05 to the broad based SPY ETF.

How much is Neonc Technologies Hldgs worth?

NTHI has a market cap of $175.23 million. This is considered a Micro Cap stock.

What are the top ETFs holding Neonc Technologies Hldgs?

The top ETF exchange traded funds that NTHI belongs to (by Net Assets): VXF, VTI, IWC.

What are the support and resistance levels for Neonc Technologies Hldgs (NTHI)?

NTHI support price is $7.54 and resistance is $8.46 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that NTHI shares will trade within this expected range on the day.